Zero Candida Technologies Reports Financial Results for Three and Six Months Ended June 30, 2025 and Provides Business Update
emerging tech investing Moore Market analysis: Zero Candida potential market will reach over $2 Billion by 2030
medical device investing Zero Candida Announces Plans to Complete Preclinical Studies for FDA Submission by Q3 2025
medical device investing Zero Candida Announces Full Transaction and Being Trading November 25th on the TSX Venture Exchange (Canada)
Goldgroup Enters Into Agreement To Sell Subsidiary Minera Apolo, S.A. de C.V., Disposing of Pinos Project
55 North Mining Appoints Wayne Parsons as Executive Chair; Strengthens Leadership as the Company Advances the Last Hope Gold Project
